New industry partner joins Our Future Health
This brings the total industry investment in Our Future Health to £160 million, meeting the target set by UK Research and Innovation, the UK Government-funded body that invests in science and research. This demonstrates the scale of the collaboration between Our Future Health the life sciences sector, the public sector and our affiliate charities, which is essential to deliver such an ambitious programme.
A collaboration between the public sector, charities and companies
Biogen is the sixteenth life sciences company* to join Our Future Health as an industry funding partner. As well as investing in the research programme, these partners are also contributing their expertise in discovering and developing new methods of prevention, early detection and treatment of diseases and health conditions.
We are also working with a number of leading health research charities that are providing valuable support and experience. Our Future Health also has funding from UK Research and Innovation to set up and begin to deliver the programme.
The UK’s largest health research programme
Our Future Health is currently inviting members of the public to join the programme in a phased region-by-region roll-out, with a goal to eventually welcome up to 5 million volunteers over the next few years.
Researchers from across the entire life sciences community, including academia, industry and the NHS, will be able to apply to study Our Future Health resources for their crucial research to accelerate the discovery and development of innovative diagnostics and treatments. Volunteers’ data will be de-identified and held in ‘trusted research environments’ that meet strict security criteria and an access board, including independent experts and members of the public, will ensure Our Future Health resources are only used for health research in the public interest.
Andrew Roddam, CEO of Our Future Health, said: “We’re looking forward to working in collaboration with Biogen to help make Our Future Health as impactful as possible. It is only with support from multiple different sectors that we can deliver a programme at this unprecedented scale.”
Sally John, Head of Translational Sciences at Biogen, said: “Biogen is proud to become a Founding Industry Member of Our Future Health and support this critical research that has the potential to improve health outcomes for communities across the UK.
“At Biogen, we believe in power of medical research to advance the scientific knowledge of serious neurological diseases. By joining this collaboration, we hope to help maximize its potential to discover and develop new methods of prevention, early detection and treatment of diseases and health conditions.”
Members of the public who are interested in taking part in Our Future Health can on our website.
*Our Future Health Founding Industry Members: